Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Search results

1-10 results from 1000 for query «pharma»

19 June, 2018 4:01 AM Strides Shasun rises 3% on USFDA nod for tablets to treat fungal infections

Shares of Strides Shasun added 3 percent in the early trade on Tuesday as company got an USFDA approval for Ketoconazole tablets USP. The company's wholly owned subsidiary Strides Pharma Global Pte has received final approval for Ketoconazole tablets USP, 200 mg from the United States Food & Drug Administration (USFDA). Ketoconazole tablets is a generic 22

18 June, 2018 8:02 AM India looking at another good year at Cannes Lions 2018, Piyush and Prasoon Pandey to be honoured

The Cannes Lions Festival of Creativity begins today and the world will see a new and improved ceremony that will last for five days, unlike nearly eight days in previous festivals. Not many were confident that the world’s most popular ad festival will take place this year due to publicized complaints from advertising holding companies on how expensive 39

15 June, 2018 5:22 AM Alembic Pharma gains 7% on EIR from USFDA for formulation facility at Panelav

Alembic Pharmaceuticals share price rallied as much as 6.6 percent in morning trade on Friday after the company received clearance report for its Panelav facility in Gujarat. The pharma company informed the exchange that it has received Establishment Inspection Report (EIR) from United States Food and Drug Administration (US FDA) after the inspection 45

8 June, 2018 7:19 AM Market Update: Dr Reddy's, Sun Pharma jump 3-5%; Infosys hits fresh 52-week high, PNB up 3%

The broader indices continue to trade on a negative note this Friday afternoon with the Nifty trading lower by 55 points at 10,712 and the Sensex shed 183 points at 35,279. Pharma stocks continued to outperform with the Index up over 2.5 percent led by Sun Pharma, Lupin, Aurobindo Pharma, Cipla, Dr Reddy's Labs, Cadila Healthcare and Glenmark Pharma 32

5 June, 2018 9:39 AM Market Update: Midcaps bleed the most dragged by Biocon, GMR Infra; RIL, Maruti top gainers

378 stocks hit a new 52-week low. These include ACC, Ajanta Pharma, BHEL, GE T&D, Granules India, HCL Infosystems, HDIL, IDFC Bank, India Cements, JK Tyre, Kwality, Mcleod Russel, PTC India Financial, Titagarh Wagons and Unitech among others. The broader indices are trading on a negative note this Tuesday afternoon with the Nifty down 72 points 55

1 June, 2018 11:29 AM Common Entrance Test rankings released in Karnataka

The Common Entrance Test (CET) rankings were released by the Karnataka Examinations Authority on Friday. Of the 1.92 lakh candidates, 1.46 lakh are eligible for engineering and technology courses, 1.13 lakh for agriculture, 1.15 lakh for veterinary courses and 1.47 lakh for B.Pharma and D. Pharma courses. The top five ranks for the engineering courses 25

28 May, 2018 11:43 AM Sensex jumps 240 points, Nifty tests 10,700

New Delhi: Markets soared over 240 points while the Nifty was just short of touching 10,700 in closing trade amidst healthy buying in pharma, banking, auto and capital goods on Monday. The BSE Sensex jumped 240.61 points or 0.69 percent to close at 35,165.48. Similarly the NSE Nifty edged up 83.50 points or 0.79 percent at 10,688.65. The rally was led by Sun Pharma 42

28 May, 2018 8:34 AM Market Update: HPCL, BPCL along with pharma stocks propel Nifty higher; Tech Mahindra falls 4%

Bajaj Finserv, Britannia Industries, Jubilant Foodworks, Kotak Mahindra Bank, NELCO and Pidilite Industries were some of the stocks that hit fresh 52-week highs in afternoon trade. The broader are trading on a positive note this Monday afternoon, with the Nifty up 88 points at 10,693 and the Sensex gaining 255 points at 35,179. The Nifty midcap 50

25 May, 2018 4:13 PM Sun Pharma net rises 7% on India, EM sales

Sun Pharmaceutical Industries Ltd. posted a 7% rise in quarterly net profit on Friday, aided by higher sales in its domestic and emerging markets. Net profit was ₹1,309 crore in its fiscal fourth quarter ended March 31, compared with ₹1,224 crore a year earlier and an average estimate of ₹947 crore in a Thomson Reuters poll of 15 analysts. Branded formulation 45

18 May, 2018 8:37 AM Bajaj Finance's surge in 2 days pushes m-cap beyond Sun Pharma, IndusInd Bank

Gaining around 20 percent in this calendar year so far, Bajaj Finance has managed to boost its market capitalisation as well. In fact, the rise in the stock between Thursday and Friday has pushed up its market cap beyond Sun Pharma and IndusInd Bank. Bajaj Finance saw its market capitalisation soaring to Rs 1,23,124.97 crore, followed by IndusInd Bank and Sun Pharma 127